Signaling Pathways - Insulin and Insulin-like Receptors - Protease-Activated Receptors - ETA Receptors - PAK
清除全部
- B6872 IRL-2500Target: ETA Receptors|ETB ReceptorsSummary: 内皮素受体拮抗剂
- B2169 IPA-31 CitationTarget: PAKSummary: 非竞争性Pak1抑制剂
- B1162 FRAX5971 CitationTarget: PAKSummary: ATP竞争性的PAK抑制剂
- B2075 Ambrisentan中文名: 安贝生坦Target: ETA ReceptorsSummary: ETA受体拮抗剂
- A8809 Vorapaxar中文名: 沃拉帕沙Target: Protease-Activated ReceptorsSummary: PAR-1拮抗剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A8229 ML161Target: Protease-Activated ReceptorsSummary: PAR1抑制剂
- A3716 PF-37583091 CitationTarget: PAKSummary: PAK4抑制剂